益气缓哮汤治疗儿童支气管哮喘慢性持续期的临床研究

目的 通过观察益气缓哮汤治疗儿童支气管哮喘慢性持续期的临床疗效,探讨其有效性.方法 选择2018年1月至2020年1月我院收治的支气管哮喘慢性持续期气虚痰结证患儿120例,随机分为观察组和对照组各60例.对照组给予雾化吸入布地奈德联合孟鲁司特钠咀嚼片治疗.观察组给予益气缓哮汤治疗.记录并比较两组患儿治疗前后哮喘症状积分...

Clinical study on treating bronchial asthma at chronic persistent phase in children with Yiqi Huanxiao decoction

Objective To observe the clinical effect of Yiqi Huanxiao decoction on bronchial asthma at chronic persistent phase in children and to explore its effectiveness.Methods Totally 120 children with chronic persistent Qi-deficiency and phlegm-stasis syndrome of bronchial asthma were randomly divided into experimental group and control group,with 60 in each group.The control group was treated with nebulized budesonide combined with montelukast sodium chewable tablets.The experimental group was treated with Yiqi Huanxiao decoction.Record and compare asthma symptom score,C-ACT score,lung function index,serum immunoglobulin level,lung HRCT mosaic sign score,and carry out the statistical analysis.Results There were 7 cases in each group which were lost to follow.The total effective rate in the experimental group was 94.34%(50/53),higher than that in the control group(81.14%,43/53),and the difference was of statistical significance(P<0.05).The asthma symptom score,C-ACT score,FEV1/FVC index,serum immunoglobulin IgA,IgG and IgM level,and lung HRCT mosaic score were significantly lower than those before treatment,and the experimental group was significantly lower than the control group,the difference being statistically significant(P<0.05).Conclusion The treatment with Yiqi Huanxiao decoction for bronchial asthma at chronic persistent phase in children is superior to traditional western medicine,which has clinical popularization value.